Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA
Dr Robert J. Motzer speaks at the ESMO 2018 congress about avelumab axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma.
To watch his interview with ecancer click here.